RxDoctor Payments Data

James Abraham, MD

Gastroenterology · Naperville, ILNPI 1427276732

Payments from drug & device makers

$3,569in general payments, 2019–2025

Across 72 payments — averaging $49.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Inspire Medical Systems, Inc.$551
  • AbbVie$215
  • Bristol Myers Squibb$213
  • Madrigal Pharmaceuticals$148
  • Johnson & Johnson$128
  • plus $543 from 9 others

What the payments were for

  • Travel & lodging$2557%
  • Food & beverage$1,81451%
  • Education$1,50042%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,569 in reported general payments places this provider in the 65th percentile of 787 gastroenterology providers in Illinois.

See all gastroenterology providers in Illinois

Medicare billing

Part B allowed, 2024
$98,626
Medicare patients
296
Services billed
729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide14$10,158
EliquisApixaban13$7,475
Pantoprazole Sodium191$2,790
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl115$1,745
Omeprazole116$1,644
Mesalamine12$1,634
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl59$860
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg31$571
Esomeprazole Magnesium12$344
Famotidine13$170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$215$10,15814 claims
PfizerEliquis$75$7,47513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 787 gastroenterology providers in Illinois.

Other gastroenterology in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →